Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
Health Industry
2,361-2,380 of 4,033 results
-
-
Best Reads Of The Week With Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
-
Podcast: KHN’s ‘What The Health?’ The Politics Of Rising Premiums And Menu Labeling
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Children’s Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.
-
When Credit Scores Become Casualties Of Health Care
The complexity of health insurance coverage rules, along with market trends that leave consumers open to more out-of-pocket costs, lead to mounting medical debt for consumers.
-
‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
-
Weak Oversight Blamed For Poor Care At California Nursing Homes Going Unchecked
The scathing report cites a significant increase in cases of poor care — especially ones with the potential to cause serious injuries or death. A state lawmaker called the findings “very, very disturbing.”
By Anna Gorman -
As Proton Centers Struggle, A Sign Of A Health Care Bubble?
Companies pushed proton machines and counted on advertising, doctors and insurers to ensure a steady business treating cancer. But the dollars haven’t flowed in as expected.
By Jay Hancock -
Postcard From D.C.: Kicking Around The ACA? For Tom Price, That’s So 2017.
The former secretary of the Department of Health and Human Services says the law eliminating penalties for most people who don’t have insurance coverage will hurt the insurance marketplaces.
-
Telemedicine Opening Doors To Specialty Care For Inmates
Getting prisoners to a medical facility can be difficult, so corrections officials are increasingly setting up telemedicine programs for specialized needs, such as psychiatric, cancer and cardiac care.
-
Best Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
-
Dissecting The Rhetoric Vs. Reality Of Trump’s Tough Talk On Drug Prices
President Donald Trump’s upcoming speech on drug prices comes after months of public comments and debate about tackling the issue.
-
Male OB-GYNs Are Growing Rare. Is That A Problem?
Nationally, women outnumber men as specialists in obstetrics and gynecology — yet women remain underrepresented in leadership roles. Many OB-GYN patients say they prefer female doctors, as residency programs strive for diversity in race, ethnicity and even gender.
-
Podcast: KHN’s ‘What The Health?’ What’s Next For The VA?
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Anna Edney of Bloomberg News and Alice Ollstein of Talking Points Memo discuss the collapse of the nomination of White House physician Ronny Jackson to head the Department of Veterans Affairs. They also discuss new bipartisan congressional efforts to address the opioid epidemic. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
-
‘Rapid Autopsy’ Programs Seek Clues To Cancer Within Hours Of Death
More than a dozen centers nationwide now ask terminal patients to allow speedy study of the diseases that kill them.
-
Hospitals Lure Diabetes Patients With Self-Care Courses, But Costs Can Weigh Heavily
Self-management classes can help the tens of millions of Americans now diagnosed with Type 2 diabetes. But the education can come with a high price tag.
-
Peak Health Plan Premiums Give Rise To Activism — And Unconventional Solutions
For people who buy their health coverage rather than get it from the government or through work, Charlottesville, Va., has claimed the title of having the country’s highest health insurance costs, and its residents are fighting back.
By Rachel Bluth -
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
-
Federal Appeals Court Puts Chill On Maryland Law To Fight Drug Price-Gouging
The decision in Maryland’s case could slow momentum for other states that are attempting to take action to curb high drug costs.
-
Congress Urged To Cut Medicare Payments To Many Stand-Alone ERs
As free-standing emergency departments multiply, the Medicare Payment Advisory Commission recommends a 30 percent reduction in some federal reimbursements for those within 6 miles of a hospital.
-
Safety Violations Compound Pain Of Painkiller Shortages
California and federal officials have cracked down on a major compounding pharmacy they say posed a threat to public safety, but their actions are worsening shortages of medications that doctors rely on to keep their patients out of pain.